Check-Cap up 12% premarket ahead of C-Scan data presentation

|About: Check-Cap Ltd. (CHEK)|By:, SA News Editor

Thinly traded nano cap Check-Cap (NASDAQ:CHEK) is up 12% premarket on modestly higher volume in apparent response to its announcement of an upcoming data presentation that it says will show C-Scan's efficacy in precancerous polyp detection for the prevention of colorectal cancer.

The results will be presented on May 20 at Digestive Disease Week in San Diego.

Subscribe for full text news in your inbox